Date Range
Date Range
Date Range
Report of the Managing Director. Report of the Chief Distribution Officer. Consolidated Statement of Changes in Equity. Notes to the Financial Statements. Notes to the Parent Company Financial Statements. Notes to the European Embedded Value Information. Report of the Reviewing Actuaries.
How we performed in 2011. Statement of changes in equity. Notes to the financial statements. Statement of changes in equity. Notes to the financial statements. Hikma Pharmaceuticals PLC Annual Report 2011.
2011 Annual Report and Financial Statements. PROUD OF THE VALUE WE CREATE. Every day people wake to put their plans, dreams and goals into action. 310 per 100,000 workforce.
We are now less than two years into our five-year Transformation Plan but our continued revenue growth and improved profits at a time when the television advertising market is broadly flat demonstrate that we are performing in line with our strategic objectives. We have made real progress to date but we are aware that there is still much to do. We remain focused on rebalancing the business and are on track to deliver the Transformation Plan.
Net funds position remains strong. Strong order book entering 2012. Group continues to invest in its future in all divisions. Increase in final dividend to 2. Designed and developed by Emperor Design.